| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study
|
Muraoka, Sei
|
|
|
|
4 |
p. 1585-1601
|
artikel
|
| 2 |
Abnormalities of Peripheral Lymphocyte Subsets in Rheumatoid Arthritis Patients Complicated with Osteoporosis
|
Cheng, Ting
|
|
|
|
4 |
p. 1049-1059
|
artikel
|
| 3 |
A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Bronchiectasis
|
Khan, Tanjila
|
|
|
|
4 |
p. 1463-1475
|
artikel
|
| 4 |
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis
|
Schmidt, Wolfgang A.
|
|
|
|
4 |
p. 793-810
|
artikel
|
| 5 |
Antirheumatic Drug Intake Influence on Occurrence of COVID-19 Infection in Ambulatory Patients with Immune-Mediated Inflammatory Diseases: A Cohort Study
|
Guillaume, Debellemanière
|
|
|
|
4 |
p. 1887-1895
|
artikel
|
| 6 |
A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
|
van der Horst-Bruinsma, Irene
|
|
|
|
4 |
p. 1775-1787
|
artikel
|
| 7 |
A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout
|
Zhang, Fengchun
|
|
|
|
4 |
p. 543-557
|
artikel
|
| 8 |
A Randomized Pharmacokinetic Study in Healthy Male Subjects Comparing a High-concentration, Citrate-free SB5 Formulation (40 mg/0.4 ml) and Prior SB5 (Adalimumab Biosimilar)
|
Ahn, So-shin
|
|
|
|
4 |
p. 1157-1169
|
artikel
|
| 9 |
A Response to: Letter to the Editor Regarding [Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind]
|
Li, Bo
|
|
|
|
4 |
p. 1241-1243
|
artikel
|
| 10 |
A Response to: Letter to the Editor Regarding the Article: “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
|
Drosos, Alexandros A.
|
|
|
|
4 |
p. 1233-1235
|
artikel
|
| 11 |
A Response to: Letter to the Editor Regarding Ultrasound Features of Adhesive Capsulitis
|
Stella, Salvatore Massimo
|
|
|
|
4 |
p. 1225-1228
|
artikel
|
| 12 |
A Review of the Clinical Effectiveness and Safety of Hybrid Cooperative Complexes in Intra-articular Viscosupplementation
|
Domżalski, Marcin
|
|
|
|
4 |
p. 957-974
|
artikel
|
| 13 |
Articular and Extra-Articular Benefits in ACR20 Non-responders at Week 104 Treated With Apremilast: Pooled Analysis of Three Randomized Controlled Trials
|
Mease, Philip J.
|
|
|
|
4 |
p. 1677-1691
|
artikel
|
| 14 |
Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap
|
Deodhar, Atul
|
|
|
|
4 |
p. 487-501
|
artikel
|
| 15 |
Association between TNFi anti-drug antibodies, smoking, and disease activity in patients with inflammatory arthritis: Results from a Norwegian cross-sectional observational study
|
Michelsen, Brigitte
|
|
|
|
4 |
p. 1171-1179
|
artikel
|
| 16 |
Association of Hydroxychloroquine Use with a Dose-Dependent Decrease in Mortality Risk in Patients with Elderly-Onset Rheumatoid Arthritis
|
Lin, Ching-Tsai
|
|
|
|
4 |
p. 861-874
|
artikel
|
| 17 |
Associations of Healthcare Utilization and Costs with Increasing Pain and Treatment Intensity Levels in Osteoarthritis Patients: An 18-Year Retrospective Study
|
Graham, Jove
|
|
|
|
4 |
p. 1061-1078
|
artikel
|
| 18 |
Benefits of Autoantibody Enrichment in Early Rheumatoid Arthritis: Analysis of Efficacy Outcomes in Four Pooled Abatacept Trials
|
Michaud, Kaleb
|
|
|
|
4 |
p. 951-967
|
artikel
|
| 19 |
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis
|
Holdsworth, Elizabeth A.
|
|
|
|
4 |
p. 1637-1649
|
artikel
|
| 20 |
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment
|
Navarini, Luca
|
|
|
|
4 |
p. 867-882
|
artikel
|
| 21 |
Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis
|
Park, Siyeon
|
|
|
|
4 |
p. 611-616
|
artikel
|
| 22 |
Clinical and Economic Burden of Herpes Zoster in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study Using Administrative Claims
|
Singer, David
|
|
|
|
4 |
p. 933-950
|
artikel
|
| 23 |
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
|
Perrotta, Fabio Massimo
|
|
|
|
4 |
p. 1193-1201
|
artikel
|
| 24 |
Clinical Characteristics of Psoriatic Arthritis in Chinese Patients: A Cross-Sectional Study
|
Song, Zhibo
|
|
|
|
4 |
p. 1845-1857
|
artikel
|
| 25 |
Clinical Management of Women with Newly Diagnosed Osteoporosis: Data from Everyday Practice in Bulgaria
|
Boyanov, Mihail A.
|
|
|
|
4 |
p. 1477-1491
|
artikel
|
| 26 |
Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis
|
Bergman, Martin J.
|
|
|
|
4 |
p. 775-792
|
artikel
|
| 27 |
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
|
Schett, Georg
|
|
|
|
4 |
p. 1017-1030
|
artikel
|
| 28 |
Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries
|
Mease, Philip J.
|
|
|
|
4 |
p. 529-542
|
artikel
|
| 29 |
Comparison Between Early-Onset and Common Gout: A Systematic Literature Review
|
Amatucci, Anthony J.
|
|
|
|
4 |
p. 809-823
|
artikel
|
| 30 |
Correction to: A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis Associated Interstitial Lung Disease and Bronchiectasis
|
Khan, Tanjila
|
|
|
|
4 |
p. 1919
|
artikel
|
| 31 |
Correction to: Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
|
Shimizu, Hirohito
|
|
|
|
4 |
p. 1053
|
artikel
|
| 32 |
Correction to: Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
|
Rehberg, Markus
|
|
|
|
4 |
p. 1921-1922
|
artikel
|
| 33 |
Correction to: Real-world Treatment Patterns and Clinical Outcomes of Baricitinib in Rheumatoid Arthritis patients in Spain: Results of a multicenter, observational study in routine clinical practice (The ORBIT-RA Study)
|
Hernández-Cruz, Blanca
|
|
|
|
4 |
p. 1245-1246
|
artikel
|
| 34 |
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
|
Askanase, Anca D.
|
|
|
|
4 |
p. 1915
|
artikel
|
| 35 |
Correction to: Risk Factors for Progression from Subclinical to Clinical Phase of Psoriatic Arthritis: A Case–Control Study
|
Wang, Yiyi
|
|
|
|
4 |
p. 1917-1918
|
artikel
|
| 36 |
COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis
|
Deodhar, Atul
|
|
|
|
4 |
p. 993-1016
|
artikel
|
| 37 |
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study
|
Scriffignano, Silvia
|
|
|
|
4 |
p. 1203-1211
|
artikel
|
| 38 |
Diabetes-Related Complications and Costs in Medicare Beneficiaries with Comorbid Rheumatoid Arthritis and Diabetes Treated with Abatacept Versus Other Targeted DMARDs
|
Patel, Vardhaman
|
|
|
|
4 |
p. 1091-1107
|
artikel
|
| 39 |
Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers
|
Saalfeld, William
|
|
|
|
4 |
p. 1493-1517
|
artikel
|
| 40 |
Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials
|
Mease, Philip
|
|
|
|
4 |
p. 1181-1191
|
artikel
|
| 41 |
Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical Settings
|
Yamairi, Fumiko
|
|
|
|
4 |
p. 811-824
|
artikel
|
| 42 |
Effectiveness of Shiatsu on Fatigue in Patients with Axial Spondyloarthritis: Protocol for a Randomized Cross-Over Pilot Study
|
Bernardinelli, Nathalie
|
|
|
|
4 |
p. 1107-1117
|
artikel
|
| 43 |
Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study
|
Heřmánková, Barbora
|
|
|
|
4 |
p. 1089-1105
|
artikel
|
| 44 |
Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study
|
Deodhar, Atul
|
|
|
|
4 |
p. 983-999
|
artikel
|
| 45 |
Effect of Upadacitinib on Quality of Life and Work Productivity in Active Non-radiographic Axial Spondyloarthritis: Results From Randomized Phase 3 Trial SELECT-AXIS 2
|
Kiltz, Uta
|
|
|
|
4 |
p. 887-899
|
artikel
|
| 46 |
Effects of Therapies on Cardiovascular Events in Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
|
Karmacharya, Paras
|
|
|
|
4 |
p. 993-1009
|
artikel
|
| 47 |
Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: Results from Study RA-BALANCE
|
Yang, Yue
|
|
|
|
4 |
p. 851-866
|
artikel
|
| 48 |
Efficacy and Safety of Ixekizumab with or Without Methotrexate in Biologic-Naïve Patients with Psoriatic Arthritis: 52-Week Results from SPIRIT-H2H Study
|
Smolen, Josef S.
|
|
|
|
4 |
p. 1021-1035
|
artikel
|
| 49 |
Efficacy of Abatacept and Adalimumab in Patients with Early Rheumatoid Arthritis With Multiple Poor Prognostic Factors: Post Hoc Analysis of a Randomized Controlled Clinical Trial (AMPLE)
|
Fleischmann, Roy
|
|
|
|
4 |
p. 559-571
|
artikel
|
| 50 |
Efficacy of Abatacept Versus Tumor Necrosis Factor Inhibitors in Anti-citrullinated Protein Antibody-Positive Patients with Rheumatoid Arthritis: Results from a Korean Nationwide Biologics Registry
|
Kim, Min Jung
|
|
|
|
4 |
p. 1143-1155
|
artikel
|
| 51 |
Esophageal Dysfunction in Systemic Sclerosis: An Update
|
Li, Bo
|
|
|
|
4 |
p. 1535-1549
|
artikel
|
| 52 |
Evaluating Inflammatory Versus Mechanical Back Pain in Individuals with Psoriatic Arthritis: A Review of the Literature
|
Grinnell-Merrick, Linda L.
|
|
|
|
4 |
p. 667-684
|
artikel
|
| 53 |
Exploring the Association Between History of Psoriasis (PSO) and Disease Activity in Patients with Psoriatic Arthritis (PsA)
|
Li, Shan-Shan
|
|
|
|
4 |
p. 1079-1090
|
artikel
|
| 54 |
Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey
|
Coates, Laura C.
|
|
|
|
4 |
p. 1741-1758
|
artikel
|
| 55 |
Health Economic Evaluation of a High and Low Molecular Weight Hyaluronic Acid Formulation for the Treatment of Knee Osteoarthritis. Post Hoc Analyses from a Randomized Clinical Trial
|
Bruyère, Olivier
|
|
|
|
4 |
p. 1119-1128
|
artikel
|
| 56 |
Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry
|
Duran, Emine
|
|
|
|
4 |
p. 969-981
|
artikel
|
| 57 |
High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame?
|
Perez-Ruiz, Fernando
|
|
|
|
4 |
p. 1011-1019
|
artikel
|
| 58 |
Identification of a Rule to Predict Response to Sarilumab in Patients with Rheumatoid Arthritis Using Machine Learning and Clinical Trial Data
|
Rehberg, Markus
|
|
|
|
4 |
p. 1661-1675
|
artikel
|
| 59 |
Immune Checkpoint Inhibitor-Associated Scleroderma-Like Syndrome: A Report of a Pembrolizumab-Induced “Eosinophilic Fasciitis-Like” Case and a Review of the Literature
|
Salamaliki, Christina
|
|
|
|
4 |
p. 1045-1052
|
artikel
|
| 60 |
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study
|
Lubrano, Ennio
|
|
|
|
4 |
p. 825-836
|
artikel
|
| 61 |
Impact of Enthesitis on Psoriatic Arthritis Patient-Reported Outcomes and Physician Satisfaction with Treatment: Data from a Multinational Patient and Physician Survey
|
Orbai, Ana-Maria
|
|
|
|
4 |
p. 937-948
|
artikel
|
| 62 |
Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks
|
Marzo-Ortega, Helena
|
|
|
|
4 |
p. 759-774
|
artikel
|
| 63 |
Implementation and Evaluation of Audit and Feedback for Monitoring Treat-to-Target (T2T) Strategies in Rheumatoid Arthritis Using Performance Measures
|
Barber, Claire E. H.
|
|
|
|
4 |
p. 909-925
|
artikel
|
| 64 |
Improvement in Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo or Adalimumab: Results from SELECT-PsA 1
|
Strand, Vibeke
|
|
|
|
4 |
p. 1789-1808
|
artikel
|
| 65 |
Incidence and Complication Rates for Total Hip Arthroplasty in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis Across Four Decades
|
Taylor-Williams, Owen
|
|
|
|
4 |
p. 685-702
|
artikel
|
| 66 |
Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
|
Curtis, Jeffrey R.
|
|
|
|
4 |
p. 1551-1563
|
artikel
|
| 67 |
Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
|
Ogdie, Alexis
|
|
|
|
4 |
p. 849-860
|
artikel
|
| 68 |
Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab
|
Kiltz, Uta
|
|
|
|
4 |
p. 1129-1142
|
artikel
|
| 69 |
Knee Osteoarthritis Pain Management with an Innovative High and Low Molecular Weight Hyaluronic Acid Formulation (HA-HL): A Randomized Clinical Trial
|
Migliore, Alberto
|
|
|
|
4 |
p. 1617-1636
|
artikel
|
| 70 |
Letter to the Editor Regarding “Colchicine Against SARS-CoV-2 Infection: What is the Evidence?”
|
Finsterer, Josef
|
|
|
|
4 |
p. 1229-1231
|
artikel
|
| 71 |
Letter to the Editor Regarding Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind
|
Bernal-Bello, David
|
|
|
|
4 |
p. 1237-1240
|
artikel
|
| 72 |
Letter to the Editor Regarding “Ultrasound Features of Adhesive Capsulitis”
|
Boudier-Revéret, Mathieu
|
|
|
|
4 |
p. 1221-1223
|
artikel
|
| 73 |
Living with Systemic Sclerosis: A Patient and Physician Perspective
|
Young, Arissa
|
|
|
|
4 |
p. 785-792
|
artikel
|
| 74 |
Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
|
Kivitz, Alan
|
|
|
|
4 |
p. 901-915
|
artikel
|
| 75 |
Long-Term Risk of Comorbidity after IgA Vasculitis in Childhood: A Population-Based Cohort Study
|
Nossent, Johannes
|
|
|
|
4 |
p. 927-935
|
artikel
|
| 76 |
Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis
|
Zhang, Xia
|
|
|
|
4 |
p. 1905-1914
|
artikel
|
| 77 |
Mortality Trends Among Patients with Rheumatoid Arthritis in Western Australia
|
Almutairi, Khalid B.
|
|
|
|
4 |
p. 1021-1037
|
artikel
|
| 78 |
MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients
|
Perrotta, Fabio Massimo
|
|
|
|
4 |
p. 1897-1904
|
artikel
|
| 79 |
Multimorbidity and Fatigue in Rheumatoid Arthritis: A Cross-Sectional Study of a Population-Based Cohort
|
Davis, John M.
|
|
|
|
4 |
p. 979-991
|
artikel
|
| 80 |
Mycophenolate Mofetil Improves Exercise Tolerance in Systemic Sclerosis Patients with Interstitial Lung Disease: A Pilot Study
|
Vaiarello, Valentina
|
|
|
|
4 |
p. 1037-1044
|
artikel
|
| 81 |
New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review
|
Perrotta, Fabio Massimo
|
|
|
|
4 |
p. 479-486
|
artikel
|
| 82 |
Occurrence of Possible Rheumatologic Immune-Related Adverse Events (rh-irAEs) Associated with Immune Checkpoint Inhibitor (ICI) Therapy
|
Anjohrin, Suzanne
|
|
|
|
4 |
p. 1651-1659
|
artikel
|
| 83 |
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis
|
Kristensen, Lars Erik
|
|
|
|
4 |
p. 1073-1087
|
artikel
|
| 84 |
Patient–Physician Communication and Perception of Treatment Goals in Rheumatoid Arthritis: An Online Survey of Patients and Physicians
|
Momohara, Shigeki
|
|
|
|
4 |
p. 917-931
|
artikel
|
| 85 |
Patient-Reported Outcomes in Psoriatic Arthritis Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: SELECT-PsA 2
|
Strand, Vibeke
|
|
|
|
4 |
p. 1827-1844
|
artikel
|
| 86 |
Pharmacokinetics and Safety of Intravenous and Subcutaneous Auto-injector Single-dose Belimumab in Healthy Chinese Volunteers: A phase 1, Randomized, Open-label Study
|
Meng, Xianmin
|
|
|
|
4 |
p. 1711-1724
|
artikel
|
| 87 |
Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)
|
Kivitz, Alan
|
|
|
|
4 |
p. 825-847
|
artikel
|
| 88 |
Physical and Emotional Burden of Rheumatoid Arthritis: Data from RA Matters, a Web-Based Survey of Patients and Healthcare Professionals
|
Alten, Rieke
|
|
|
|
4 |
p. 587-597
|
artikel
|
| 89 |
Plasma Exchange in a Patient with Immune Thrombocytopenia Associated with Antiphospholipid Syndrome Hospitalized for COVID-19
|
Boggio, Federico
|
|
|
|
4 |
p. 1213-1219
|
artikel
|
| 90 |
Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
|
Askanase, Anca D.
|
|
|
|
4 |
p. 1871-1886
|
artikel
|
| 91 |
Predicting Survival Across Acute Exacerbation of Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myositis: The GAP-ILD Model
|
Cao, Heng
|
|
|
|
4 |
p. 967-978
|
artikel
|
| 92 |
Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis
|
Zabotti, Alen
|
|
|
|
4 |
p. 1519-1534
|
artikel
|
| 93 |
Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2)
|
Schett, Georg
|
|
|
|
4 |
p. 1247-1248
|
artikel
|
| 94 |
Racial Differences in Prevalence and Treatment for Psoriatic Arthritis and Ankylosing Spondylitis by Insurance Coverage in the USA
|
Ogdie, Alexis
|
|
|
|
4 |
p. 1725-1739
|
artikel
|
| 95 |
Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
|
Reed, George W.
|
|
|
|
4 |
p. 573-586
|
artikel
|
| 96 |
Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry
|
Moreno-Ramos, Manuel José
|
|
|
|
4 |
p. 1031-1047
|
artikel
|
| 97 |
Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review
|
Huang, Shirley P.
|
|
|
|
4 |
p. 975-991
|
artikel
|
| 98 |
Real-World Effectiveness of Belimumab in the Treatment of Systemic Lupus Erythematosus: Pooled Analysis of Multi-Country Data from the OBSErve Studies
|
Collins, Christopher E.
|
|
|
|
4 |
p. 949-965
|
artikel
|
| 99 |
Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry
|
Curtis, Jeffrey R.
|
|
|
|
4 |
p. 1055-1072
|
artikel
|
| 100 |
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
|
Askanase, Anca D.
|
|
|
|
4 |
p. 893-908
|
artikel
|
| 101 |
Risk of Potential Glucocorticoid-Related Adverse Events in Patients with Giant Cell Arteritis: Results from a USA-Based Electronic Health Records Database
|
Best, Jennie H.
|
|
|
|
4 |
p. 599-610
|
artikel
|
| 102 |
Role of Collagen Derivatives in Osteoarthritis and Cartilage Repair: A Systematic Scoping Review With Evidence Mapping
|
Honvo, Germain
|
|
|
|
4 |
p. 703-740
|
artikel
|
| 103 |
Should We Use bDMARDs as an Induction Therapy in Early and Severe Rheumatoid Arthritis? Results at 5 years from the ERA UCLouvain Brussels Cohort
|
Sapart, Emilie
|
|
|
|
4 |
p. 875-886
|
artikel
|
| 104 |
Significance of Macrophage Subtypes in the Peripheral Blood of Children with Systemic Juvenile Idiopathic Arthritis
|
Feng, Dan
|
|
|
|
4 |
p. 1859-1870
|
artikel
|
| 105 |
Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis
|
Schnitzer, Thomas J.
|
|
|
|
4 |
p. 1759-1774
|
artikel
|
| 106 |
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
|
Lubrano, Ennio
|
|
|
|
4 |
p. 521-528
|
artikel
|
| 107 |
Systematic Review and Meta-Analysis of Inflammatory Bowel Disease Adverse Events with Anti-Interleukin 17A Agents and Tumor Necrosis Factor Inhibitors in Rheumatic Disease and Skin Psoriasis
|
Truong, Steven L.
|
|
|
|
4 |
p. 1603-1616
|
artikel
|
| 108 |
The Diagnosis and Treatment of Adult Patients with SAPHO Syndrome: Controversies Revealed in a Multidisciplinary International Survey of Physicians
|
Furer, Victoria
|
|
|
|
4 |
p. 883-891
|
artikel
|
| 109 |
The Non-medical Switch from Reference Adalimumab to Biosimilar Adalimumab is Highly Successful in a Large Cohort of Patients with Stable Inflammatory Rheumatic Joint Diseases: A Real-Life Observational Study
|
van Adrichem, Roxanne C. S.
|
|
|
|
4 |
p. 1109-1118
|
artikel
|
| 110 |
The Recent Outbreak of COVID-19 in China During the Omicron Variant Predominance: Clinical Features and Outcomes in Patients with Autoimmune Inflammatory Rheumatic Diseases
|
Geng, Yan
|
|
|
|
4 |
p. 1039-1053
|
artikel
|
| 111 |
The Risk Factors of Exacerbation in Interstitial Pneumonia With Autoimmune Features: A Single-Center Observational Cohort Study
|
Murata, Okinori
|
|
|
|
4 |
p. 1693-1710
|
artikel
|
| 112 |
The Role of CCL3 in the Pathogenesis of Rheumatoid Arthritis
|
Yang, Ying-Li
|
|
|
|
4 |
p. 793-808
|
artikel
|
| 113 |
Tofacitinib Reduces Spinal Inflammation in Vertebral Bodies and Posterolateral Elements in Ankylosing Spondylitis: Results from a Phase 2 Trial
|
Østergaard, Mikkel
|
|
|
|
4 |
p. 1001-1020
|
artikel
|
| 114 |
Treatment Patterns and Resource Utilization of Pregnant Women with Inflammatory Rheumatic Diseases or Psoriasis in Germany: A Claims Database Analysis
|
Blaschke, Katja
|
|
|
|
4 |
p. 1565-1584
|
artikel
|
| 115 |
Treat-To-Target and Treat-To-Budget in Rheumatoid Arthritis: Measuring the Value of Individual Therapeutic Interventions
|
Sacristán, José A.
|
|
|
|
4 |
p. 473-477
|
artikel
|
| 116 |
Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study
|
Genovese, Mark C.
|
|
|
|
4 |
p. 503-520
|
artikel
|
| 117 |
Ultrasound Effectiveness of Steroid Injection for hand Psoriatic Dactylitis: Results from a Longitudinal Observational Study
|
Girolimetto, Nicolò
|
|
|
|
4 |
p. 1809-1826
|
artikel
|
| 118 |
Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review
|
St Clair-Jones, Anja
|
|
|
|
4 |
p. 741-757
|
artikel
|
| 119 |
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio
|
Gosselt, Helen R.
|
|
|
|
4 |
p. 837-850
|
artikel
|
Tijdschrift beschrijving